Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 6/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.32 |
| ▸ | ACACB | O00763 | 1/20 | 0.32 |
| ▸ | ACACA | Q13085 | 1/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | TYK2 | P29597 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953307 | 0.91 | AAK1 (0.45) | AAK1LMNARAB9AMMP1KDM4E | |
| SCHEMBL27393615 | 0.86 | AAK1 (0.48) | AAK1LMNARAB9ASCN9AMMP1 | |
| SCHEMBL30953221 | 0.86 | AAK1 (0.48) | AAK1LMNARAB9ASCN9AMMP1 | |
| SCHEMBL30953440 | 0.85 | AAK1 (0.51) | AAK1LMNARAB9AMMP1KDM4E | |
| SCHEMBL30953363 | 0.85 | AAK1 (0.40) | AAK1LMNARAB9ASCN9AMMP1 | |
| SCHEMBL30953402 | 0.84 | AAK1 (0.60) | AAK1LMNARAB9AMMP1 | |
| SCHEMBL30953339 | 0.83 | AAK1 (0.50) | AAK1LMNARAB9AMMP1KDM4E | |
| SCHEMBL30953274 | 0.83 | AAK1 (0.48) | AAK1LMNARAB9ASCN9AMMP1 | |
| SCHEMBL30953269 | 0.82 | AAK1 (0.48) | AAK1LMNARAB9ASCN9AMMP1 | |
| SCHEMBL27393638 | 0.82 | AAK1 (0.48) | AAK1LMNARAB9ASCN9AMMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |